Compare BLK & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLK | MDT |
|---|---|---|
| Founded | 1988 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 163.6B | 131.9B |
| IPO Year | 2024 | 2014 |
| Metric | BLK | MDT |
|---|---|---|
| Price | $956.18 | $91.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 19 |
| Target Price | ★ $1,259.60 | $109.82 |
| AVG Volume (30 Days) | 751.0K | ★ 8.0M |
| Earning Date | 04-20-2026 | 05-19-2026 |
| Dividend Yield | 2.40% | ★ 3.12% |
| EPS Growth | N/A | ★ 30.80 |
| EPS | ★ 35.31 | 2.76 |
| Revenue | $12,794,000,000.00 | ★ $33,537,000,000.00 |
| Revenue This Year | $17.60 | $8.91 |
| Revenue Next Year | $10.57 | $6.75 |
| P/E Ratio | ★ $26.96 | $32.90 |
| Revenue Growth | ★ 16.18 | 3.62 |
| 52 Week Low | $773.74 | $79.55 |
| 52 Week High | $1,219.94 | $106.33 |
| Indicator | BLK | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 26.31 | 29.39 |
| Support Level | N/A | $88.29 |
| Resistance Level | $1,001.16 | $93.13 |
| Average True Range (ATR) | 36.56 | 1.92 |
| MACD | -12.58 | -0.76 |
| Stochastic Oscillator | 18.44 | 12.99 |
BlackRock is the largest asset manager in the world, with $14.041 trillion in assets under management at the end of December 2025. Its product mix is diverse, with 55% of managed assets in equity strategies, 23% in fixed income, 9% in multi-asset classes, 6% in money market funds, and 5% in alternatives. Passive strategies account for more than two-thirds of long-term AUM, with the company's ETF platform maintaining a leading market share domestically and on a global basis. Product distribution is weighted more toward institutional clients, which, by our calculations, account for around 80% of AUM. BlackRock is geographically diverse, with clients in more than 100 countries and more than one-third of managed assets coming from investors domiciled outside the US and Canada.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.